Cell-Free DNA Mini-Circle Synthesis via Rolling Circle Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating high-quality circular nucleic acids for therapeutic applications are limited by contamination risks, laborious purification processes, and low transformation efficiencies, particularly due to the rapid degradation of linear DNA molecules by nucleases and the complexity of converting concatamers to circular forms.
Innovation Solution
A cell-free system using rolling circle amplification and site-specific recombination proteins like Cre recombinase to generate circular nucleic acids from templates engineered with recombination sites, such as loxP sites, allowing for efficient conversion of tandem repeat sequences into circular forms without bacterial contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If linear DNA molecules are used for therapeutic applications, then they are easier to synthesize, but they are rapidly degraded by nucleases limiting their use
Solution Approach 1:
The linear DNA is segmented into multiple smaller linear fragments through controlled partial digestion or design, which are then circularized individually. This segmentation allows each fragment to be more stable while maintaining ease of synthesis through modular assembly
Solution Approach 2:
Instead of attempting to stabilize linear DNA directly, the invention inverts the approach by converting the linear DNA into circular form after synthesis. The circularization transforms the unstable linear ends into stable continuous structures, resolving the degradation issue while preserving synthesis ease
2Productivity
If bacterial cell culture methods are used to generate circular nucleic acids, then large-scale production is achieved, but contamination risks and purification complexity increase
Solution Approach 1:
The invention extracts the circularization step from the bacterial culture process entirely. By performing chemical or enzymatic circularization on synthesized linear DNA in vitro, it removes the source of contamination (bacterial cells) while maintaining production capability, thereby simplifying purification requirements
Solution Approach 2:
The invention introduces an intermediary circularization step using chemical reagents or enzymes as mediators between linear DNA synthesis and final circular product formation. This intermediary process enables large-scale production without bacterial contamination, reducing purification complexity
3Productivity
If rolling circle amplification is used to generate concatamers, then amplification efficiency is improved, but transformation efficiency decreases due to linear tandem repeat structures
Solution Approach 1:
The invention performs preliminary circularization of the concatamer structures before transformation. By circularizing the amplified DNA products in advance, the transformation-competent circular form is prepared beforehand, maintaining the high amplification efficiency of RCA while enabling efficient transformation
Solution Approach 2:
Instead of attempting to transform linear concatamers directly, the invention inverts the approach by circularizing the concatamers first and then transforming. This reversal of the typical linear-to-circular conversion timing preserves amplification efficiency while achieving transformation competence
4Reliability
If multiple enzymatic reactions are used to convert concatamers to circular nucleic acids, then circularization is achieved, but process time and cost increase
Solution Approach 1:
The invention merges multiple enzymatic functions into a single reaction step or uses a single enzyme that performs both cleavage and circularization functions. This consolidation maintains complete circularization while significantly reducing process time and operational complexity
Solution Approach 2:
The invention employs a universal enzyme or reagent system that can handle different concatamer structures and perform circularization in a single step. This multi-functional approach achieves complete circularization without requiring multiple specialized enzymatic reactions, reducing time and cost
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces high-quality circular nucleic acids with enhanced transformation efficiencies and simplified purification, reducing contamination risks and production costs, making them suitable for large-scale therapeutic applications like DNA vaccines and gene therapy.
Implementation Method 1
amplifying the circular nucleic acid template by rolling circle amplification to form a concatamer
Implementation Method 2
incubating the tandem repeat nucleic acid sequence with a recombination protein to generate a circular nucleic acid
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Methods and kits for generating circular nucleic acids in a cell-free system, and uses for the generated circular nucleic acids are provided. The methods comprise in vitro amplification of a nucleic acid template comprising a recombination site to produce tandem repeat nucleic acid sequence, and employ a recombination protein to generate the circular nucleic acids from the tandem repeat nucleic acid sequence.